Quantcast

BIO-key® International to Exhibit at Allscripts 2010 Client Experience Conference

August 4, 2010

WALL, N.J., Aug. 4 /PRNewswire-FirstCall/ — BIO-key International, Inc. (OTC Bulletin Board: BKYI), a leader in finger-based biometric identification solutions will be showcasing its fingerprint biometric solutions at the Allscripts 2010 Client Experience Conference being held at the Mandalay Bay Hotel in Las Vegas on August 5-7, 2010.

(Logo: http://photos.prnewswire.com/prnh/20050509/BIOKEYLOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO)

The Allscripts Client Experience (ACE) is the leading industry user conference. In this venue, Allscripts and Allscripts partners showcase their portfolio of award-winning ambulatory, acute and post acute solutions along with many other products and services. More than 3,000 clients, partners and Allscripts staff participate in this event to keep abreast of healthcare solutions and new innovations.

Year after year, ACE attracts more physicians, CEOs, CIOs, administrators, IT staff, billing staff, and many other healthcare professionals and decision makers than almost any other event in healthcare. These groups range from the solo practitioner to the largest medical centers, academic medical groups, hospitals, post acute and homecare centers, MSO’s, billing services and integrated delivery networks.

In booth #138, BIO-key will be showcasing its biometric fingerprint authentication solutions which have been integrated into Allscripts Enterprise EHR, providing users with a more secure and convenient alternative to passwords and tokens. Medical staffs at Allscripts EHR deployments across the country have been using this convenient alternative to passwords and tokens for years to quickly and easily establish their identity.

In addition to the superior security and convenience BIO-key’s fingerprint biometric solutions offer healthcare organizations for establishing the identity of staff and patients, they also comply with HIPAA regulations as well as the new DEA regulations for two-factor authentication when ePrescribing controlled substances.

About BIO-key

BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers. BIO-key’s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world’s largest identification deployments to improve security, guarantee identity, and help reduce identity theft. BIO-key’s technology is offered directly or by market leading partners around the world. (http://www.bio-key.com)

BIO-key Safe Harbor Statement

Certain statements contained in this press release may be construed as “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 (the “Act”). The words “estimate,” “project,” “intends,” “expects,” “anticipates,” “believes” and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management’s beliefs, as well as assumptions made by, and information currently available to, management pursuant to the “safe-harbor” provisions of the Act. These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements. These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, and our ability to attract and retain key personnel. For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2008 and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.

SOURCE BIO-key International, Inc.


Source: newswire



comments powered by Disqus